Treatment group:Shengxuening tablets

2 trials

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Conditions

Cancer anemia

Phase 4

clinical efficacy of Shengxuening tablets for cancer anemia:a randomized, double-blind study

Active, not recruitingITMCTR2100004715

Dongzhimen Hospital Affiliated to Beijing University of Chinese MedicineCancer anemia

Start: 2021-04-09Updated: 2023-02-20

clinical efficacy of Shengxuening tablets for cancer anemia:a randomized, double-blind study

RecruitingChiCTR2100045238

Dongzhimen Hospital Affiliated to Beijing University of Chinese MedicineCancer anemia

Start: 2021-04-09Updated: 2021-11-16